Perspective Therapeutics CATX
NYSE CATX
$0.86 +0.02 (+2.38%)
At close: Nov 9, 2026 · 4:00 PM EST

Perspective Therapeutics (CATX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Perspective Therapeutics (CATX) posted Return on Capital Employed [ROCE] of -33.38% for Q2 2026, up 2.28 percentage points from -35.66% a year earlier and up 4.54 percentage points from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Perspective Therapeutics' Return on Capital Employed [ROCE] came in at -41.24%, up 3.91 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +5.19 percentage points (FY2020 to FY2025).
  • In prior years, Perspective Therapeutics' Return on Capital Employed [ROCE] was -45.16% in FY2024 (+20.53 pp), -65.69% in FY2023 (-50.77 pp), -14.91% in FY2022 and -9.13% in FY2021 (+37.31 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -5.30 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 20.12 percentage points; the weakest was Q4 2023, with a drop of 26.98 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -37.92% (Q1 2026), -43.66% (Q4 2025) and -41.40% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.52%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 21.60%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.33%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.91%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 17.37%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.15%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 11.32%
10 Perspective Therapeutics 104.44 Mn -132.46 Mn - -33.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -33.38%
Mar 31, 2026 -37.92%
Dec 31, 2025 -43.66%
Sep 30, 2025 -41.40%
Jun 30, 2025 -35.66%
Mar 31, 2025 -30.91%
Dec 31, 2024 -26.12%
Sep 30, 2024 -15.98%
Jun 30, 2024 -15.15%
Mar 31, 2024 -25.45%
Dec 31, 2023 -46.24%
Sep 30, 2023 -27.15%
Jun 30, 2023 -20.44%
Mar 31, 2023 -18.58%
Dec 31, 2022 -13.17%
Sep 30, 2022 -15.68%
Jun 30, 2022 -11.73%
Mar 31, 2022 -9.85%
Dec 31, 2021 -8.72%
Sep 30, 2021 -7.39%
API Access

Perspective Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY